1. Home
  2. ATLO vs INBX Comparison

ATLO vs INBX Comparison

Compare ATLO & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$27.61

Market Cap

239.2M

Sector

Finance

ML Signal

HOLD

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$58.33

Market Cap

999.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
INBX
Founded
1903
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.2M
999.7M
IPO Year
2001
2024

Fundamental Metrics

Financial Performance
Metric
ATLO
INBX
Price
$27.61
$58.33
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
N/A
AVG Volume (30 Days)
36.4K
143.2K
Earning Date
04-16-2026
03-19-2026
Dividend Yield
2.90%
N/A
EPS Growth
8.03
N/A
EPS
0.38
N/A
Revenue
N/A
$1,300,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$72.66
N/A
Revenue Growth
N/A
550.00
52 Week Low
$16.09
$10.81
52 Week High
$28.35
$94.57

Technical Indicators

Market Signals
Indicator
ATLO
INBX
Relative Strength Index (RSI) 60.11 33.28
Support Level $26.00 $28.54
Resistance Level $28.28 $85.97
Average True Range (ATR) 0.65 4.27
MACD 0.05 -0.55
Stochastic Oscillator 86.81 8.45

Price Performance

Historical Comparison
ATLO
INBX

About ATLO Ames National Corporation

Ames National Corporation is a bank holding company based in the United States. Through its subsidiaries, it provides a range of banking and other financial products and services to customers in Iowa, mainly in Boone, Clarke, Hancock, Marshall, Polk, Story, Taylor, and Union in central, north-central, and south-central Iowa. The Group offers several financial products and services, including checking and savings accounts, time deposits, commercial, construction, and agricultural loans, personal loans, lines of credit, cash management services, merchant credit card processing, safe deposit boxes, and ATM services, among others. It caters to the banking needs of a diverse range of customers, including individuals, businesses, professionals, and enterprises.

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

Share on Social Networks: